Retinoblastoma: Direct chemotherapeutic drug delivery into the vitreous cavity

British Journal of Ophthalmology

Volumn 96, Issue 4, 2012, Pages 473-474

  Seregard, Stefan ^a   Singh, Arun D ^b  

^a ST ERIK S EYE HOSPITAL   (Sweden)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; MELPHALAN;

ADVANCED CANCER; ADVERSE OUTCOME; ASPIRATION BIOPSY; CANCER CELL; CANCER CHEMOTHERAPY; DRUG ADMINISTRATION ROUTE; DRUG DELIVERY SYSTEM; DRUG SAFETY; ECHOGRAPHY; EDITORIAL; FOLLOW UP; FREEZE THAWING; HUMAN; NEEDLE; PRIORITY JOURNAL; RETINOBLASTOMA; RISK FACTOR; SALVAGE THERAPY; SYSTEMIC THERAPY; TUMOR SEEDING;

ANTINEOPLASTIC AGENTS; HUMANS; INTRAVITREAL INJECTIONS; RETINAL NEOPLASMS; RETINOBLASTOMA;

EID: 84863404136     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjophthalmol-2012-301528     Document Type: Editorial

References (17)

1. Abramson DH, Frank CM, Dunkel IJ. A phase I/II study of subconjunctival carboplatin for intraocular retinoblastoma. Ophthalmology 1999;106:1947-50.
2. Abramson DH, Dunkel IJ, Brodie SE, et al. A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma: initial results. Ophthalmology 2008;115:1398-404.
3. Eagle RC Jr, Shields CL, Bianciotti C, et al. Histopathologic observations after intra-arterial chemotherapy for retinoblastoma. Arch Ophthalmol 2011;129:1416-21.
4. Munier FL, Beck-Popovic M, Balmer A, et al. Occurrence of sectoral choroidal occlusive vasculopathy and retinal arteriolar embolization after superselective ophthalmic artery chemotherapy for advanced intraocular retinoblastoma. Retina 2011;31:566-73.
5. Martin DF, Maguire M, Ying GS, et al CATT Research Group. Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N Engl J Med 2011;364:1897-908.
6. Karcioglu ZA. Fine needle aspiration biopsy (FNAB) for retinoblastoma. Retina 2002;22:707-10. (Pubitemid 35462498)
7. Karcioglu ZA, Gordon RA, Karcioglu GL. Tumor seeding in ocular fine needle aspiration biopsy. Ophthalmology 1985;92:1763-7. (Pubitemid 16172084)
8. Henkes HE, Manschot WA. The danger of diagnostic biopsy in eyes suspected of an intraocular tumor. Ophthalmologica 1963;145:467-9.
9. Ericson L, Rosengren B. Present therapeutic resources in retinoblastoma. Acta Ophthalmol 1961;39:569-76.
10. Seregard S, Kock E, af Trampe E. Intravitreal chemotherapy for recurrent retinoblastoma in an only eye. Br J Ophthalmol 1995;79:194-5.
11. Kivela T, Eskelin S, Paloheimo M. Intravitreal methotrexate for retinoblastoma. Ophthalmology 2011;118:1689.
12. Suzuki S, Kaneko A. Management of intraocular retinoblastoma and ocular prognosis. Int J Clin Oncol 2004;9:1-6. (Pubitemid 38470656)
13. Smith SJ, Pulido JS, Salomão DR, et al. Combined intravitreal and subconjunctival carboplatin for retinoblastoma with vitreous seeds. Br J Ophthalmol Published Online First: 24 February 2012. doi:10.1136/bjophthalmol- 2011-300829
14. Munier FL, Soliman SE, Moulin A, et al. Profiling safety of intravitreal injections for retinoblastoma usin an antireflux procedure and sterilization of the needle track. Br J Ophthalmol Published Online First: 24 February 2012. doi:10.1136/bjophthalmol-2011-301016
15. Munier FL, Gaillard MC, Balmer A, et al. Intravitreal chemotherapy for vitreous disease in retinoblastoma revisted: from prohibition to conditional indications. Br J Ophthalmol 2012. In press.
16. Edelhauser HF, Rowe-Rendleman CL, Robinson MR, et al. Ophthalmic drug delivery systems for the treatment of retinal diseases: basic research to clinical applications. Invest Ophthalmol Vis Sci 2010;51:5403-20.
17. Patel SR, Lin AS, Edelhauser HF, et al. Suprachoroidal drug delivery to the back of the eye using hollow microneedles. Pharm Res 2011;28:166-76.